Document is current
Any future updates will be listed below
-
Authors
Ramaker, Ryne C.
Zhang, Yuchen
Strickler, John H.
Allen, Peter
Abbruzzese, James
Counter, Christopher M.
-
Funding
Funding for this research was provided by:
Hopper Belmont Foundation Inspiration Award (n/a)
Duke Office of Physician Scientist Development Technician Support Award (n/a)
National Cancer Institute (CA257816)
- License Information
-
More Information
Article History
Received: 12 December 2025
Accepted: 17 March 2026
First Online: 3 April 2026
Competing interests
: Pending Patents: C.M.C. is a co-inventor listed on a pending patent application entitled “Methods for detecting oncogenic Kras mutations.” Application number: US-20240141440-A1. Inventors: Christopher Counter and Siqi Li. Current status: pending. This patent covers use Maximum Depth Sequencing to detect mutations in human KRAS. The other authors do not have a competing interest.
